Business Standard

Monday, December 23, 2024 | 02:52 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Glenmark Pharmaceuticals gets ANDA approval for Bendamustine Hydrochloride for Injection

Image

Capital Market

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Bendamustine Hydrochloride for Injection, 25 mg/ vial and 100 mg/ vial, the therapeutic equivalent to the reference listed drug product, Treanda for Injection, 25 mg/ vial and 100 mg/vial, of Cephalon Inc. This marks, Glenmark's first injectable granted approvals by the USFDA.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 28 2016 | 9:19 AM IST

Explore News